Supernus Pharmaceuticals, Inc. (LON:0LB2)
London
· Delayed Price · Currency is GBP · Price in USD 33.25
+0.84 (2.59%)
At close: Jul 10, 2025
Supernus Pharmaceuticals Market Cap
Supernus Pharmaceuticals has a market cap or net worth of 1.53 billion as of July 11, 2025. Its market cap has increased by 31.26% in one year.
Market Cap
1.53B
Enterprise Value
1.21B
Revenue
517.02M
Ranking
n/a
PE Ratio
31.93
Stock Price
33.25
Market Cap Chart
Since May 1, 2012, Supernus Pharmaceuticals's market cap has increased from 79.17M to 1.53B, an increase of 1,832.54%. That is a compound annual growth rate of 25.15%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 164.77B |
| GSK plc | 58.85B |
| Haleon | 33.44B |
| Smith & Nephew | 10.11B |
| ConvaTec Group | 5.40B |
| Hikma Pharmaceuticals | 4.40B |
| HUTCHMED (China) | 1.98B |
| Oxford Nanopore Technologies | 1.47B |